ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months
Year: 2020
Type: article
Study design: Observational Study
Source: Thrombosis Research
Authors: Giancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, Sean Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jimenez, Bernd Brüggenjürgen, Pierre Levy, Petra Laeis, Eva-Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Marius Constantin Manu, Paul-Egbert Reimitz, Peter Bramlage, Alexander T. Cohen
Institutions: University of Perugia, LMU Klinikum, Ludwig-Maximilians-Universität München, Cliniques Universitaires Saint-Luc, UCLouvain, Mater Misericordiae University Hospital, Medical University of Vienna, Amsterdam UMC Location University of Amsterdam, University of Bern, University Hospital of Bern, Hospital Universitario Ramón y Cajal, Steinbeis University Berlin, Université Paris Sciences et Lettres, Laboratoire d’Economie de Dauphine, Université Paris Dauphine-PSL, Daiichi Sankyo (Germany), IPPMed (Germany), King's College London, Guy's and St Thomas' NHS Foundation Trust
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3085713416